Lannett Launches Authorized Tirosint In US

Company Expects To Be ‘One Of Two Suppliers’ Of Generic Tirosint

Lannett has launched levothyroxine sodium capsules, an authorized generic version of Tirosint, in partnership with IBSA in the US. The company faces the possibility of competition, as Teva may enter the market with certain generic strengths.

Thyroid
Lannett expands its thyroid deficiency product portfolio with authorized Tirosint • Source: Shutterstock

More from Deals

More from Business